Industry
Biotechnology
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Avi Kapoor
July 29, 2024 | 5:19 pm
Portfolio Pulse from Avi Kapoor
July 29, 2024 | 2:12 pm
Portfolio Pulse from Avi Kapoor
July 25, 2024 | 6:12 pm
Portfolio Pulse from Avi Kapoor
July 25, 2024 | 10:36 am
Portfolio Pulse from Avi Kapoor
July 18, 2024 | 11:55 am
Portfolio Pulse from Benzinga Newsdesk
July 08, 2024 | 12:13 pm
Portfolio Pulse from Benzinga Insights
June 14, 2024 | 8:31 pm
Portfolio Pulse from Avi Kapoor
June 14, 2024 | 12:19 pm
Portfolio Pulse from Avi Kapoor
June 13, 2024 | 6:07 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.